FDA

Federal health agencies have connected an E. coli outbreak to a raw milk cheese brand, according to the CDC and FDA. The announcement, picked up by multiple US news outlets, signals an ongoing food safety investigation. Details on the brand, the number of illnesses, and affected states have not yet been made available in the initial reports.

A former head of the US Food and Drug Administration has warned that the ongoing cyclosporiasis outbreak in the United States is not 'fully under control,' despite official responses. The intestinal illness, typically linked to contaminated produce, has been the subject of public health tracking, and the comment raises concerns about the effectiveness of containment efforts so far.

Federal health officials are investigating an E. coli outbreak tied to raw milk cheese that has sickened 13 people across the United States, according to the FDA. Eight of those infected required hospitalization. The announcement has renewed attention on the risks of unpasteurized dairy products and may prompt recalls or consumer warnings as the investigation continues.

The FDA has announced a recall of raw milk cheese linked to an E. coli outbreak in the United States. The recall is being widely reported across local and national news outlets. Consumers are being urged to check whether they have the affected cheese and to discard it, as E. coli infections can cause serious illness. Details on the brand involved and the number of cases have not been confirmed.

The FDA has announced a new nationwide recall of a blood pressure medication. Few details beyond the announcement are available so far, including which specific drug, manufacturer, and lot numbers are affected, or the reason for the recall. Patients taking blood pressure medication are advised to watch for updates from the FDA and their pharmacies before making any changes to their treatment.

Reports say the US Food and Drug Administration has approved the first mRNA-based flu vaccine, marking a new application of the technology widely used in COVID-19 vaccines. The trending term reflects news headlines about the decision. Beyond the headline itself, the available posts contain no further details on the vaccine's maker, availability, or public reaction, so what people are saying beyond sharing the news is not clear from the posts.

AbbVie has won US Food and Drug Administration approval for a Parkinson's disease treatment developed through its $8.7 billion acquisition of Cerevel Therapeutics. The approval validates the company's large bet on neurology and gives AbbVie a new product in a market where its flagship franchise faces eventual competition. Industry observers are watching how quickly the drug can reach patients and generate revenue.

The FDA has approved Onswik, a once-weekly insulin intended for adults with type 2 diabetes. It was not approved for type 1 diabetes. Coverage highlights what the clinical trials showed about effectiveness and the side effects patients should know about. The approval is drawing attention as a potential convenience shift for diabetes management, reducing injections from daily to weekly.

Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.

A recall of a thyroid medication has been designated at the FDA's most serious risk level, known as Class I, reserved for situations where exposure could cause serious health problems or death. People with thyroid conditions are being advised to check their medication lots and contact their pharmacist or doctor if affected.

Biotech firm Disc Medicine is under scrutiny after a regulatory setback with the FDA, alongside legal investigations into the company. Market analysts are debating whether the stock, trading under the ticker IRON, is now undervalued given the combined regulatory and legal pressures. Investors are weighing the discounted share price against uncertainty over the drug's approval prospects and the outcome of the probes.

The FDA has released new guidance establishing a common playbook for companies developing surgical robots. The framework is expected to give robotic surgery manufacturers a clearer, more consistent path through regulatory review. Industry watchers say it could lower barriers for new entrants and speed approval of next-generation surgical robotics systems across the market.